HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Imogam rage prescription assessment in the rabies prophylaxis center of Poitiers].

AbstractOBJECTIVES:
Imogam rage (IgR) prescriptions were assessed in the rabies prophylaxis centre of Poitiers (France).
MATERIAL AND METHODS:
All medical records closed between January 1 and June 1, 2005 were retrospectively analyzed. An infectious disease specialist examined the pertinence of IgR prescription according to WHO references adapted to the epidemiological situation by the Pasteur Institute French rabies center. The indicator used was the proportion of patients treated by IgR among all patients treated by vaccination or vaccination with IgR.
RESULTS:
During the study period, 69 medical records have bewereen analyzed: 48 (70%) patients were treated including 22 (46%) with IgR. Imogam rage indication was not appropriate for 21 (95%) patients (one contact with a rodent, 8 low gravity contact, 12 contacts with a French animal) that is to say 86 IgR vials. The direct cost was 8,032 euros.
CONCLUSION:
This assessment permitted to underline an overprescription of IgR, to adapt guidelines to the local situation, and to improve care quality by adaptating medical record files, improving the prescription decisional tree and the local guidelines, and improving the training of interns.
AuthorsM Albouy-Llaty, G Le Moal, G Bouche, A Dupuis, B Becq-Giraudon, V Migeot
JournalMedecine et maladies infectieuses (Med Mal Infect) Vol. 37 Issue 2 Pg. 108-11 (Feb 2007) ISSN: 0399-077X [Print] France
Vernacular TitleEvaluation de la pertinence de la prescription d'Imogam rage au centre antirabique de Poitiers.
PMID17254729 (Publication Type: Journal Article)
Chemical References
  • Imogam rage
  • Rabies Vaccines
Topics
  • Algorithms
  • Animals
  • Animals, Domestic
  • Animals, Wild
  • Bites and Stings (therapy)
  • Case Management
  • Chiroptera
  • Drug Costs
  • Drug Prescriptions (statistics & numerical data)
  • Drug Utilization
  • Environmental Exposure
  • France
  • Health Facilities (statistics & numerical data)
  • Humans
  • Immunotherapy, Active (economics, statistics & numerical data)
  • Rabies (prevention & control, transmission)
  • Rabies Vaccines (economics, therapeutic use)
  • Rodentia
  • Unnecessary Procedures

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: